Diffusion dynamics of technological innovations in health: the case of an innovative medical imaging technology in France
-
By
-
Renaud Guignard
-
Bénédicte Geffroy
-
Valérie Fernandez
-
June 10, 2026
-
Clinical Scorecard: Exploring the Spread of Health Technology Innovations: A Study on PET-CT Imaging in France
At a Glance
| Category | Detail |
| Condition | Cancer diagnosis and treatment assessment |
| Key Mechanisms | PET-CT technology enables precise imaging for cancer care |
| Target Population | Patients requiring cancer imaging and treatment evaluation |
| Care Setting | Healthcare facilities utilizing nuclear medicine |
Key Highlights
- Expansion of PET-CT technology supply nationwide in France from 2013 to 2022
- Significant regional disparities in actual PET-CT utilization
- Factors influencing diffusion include institutional, organizational, and professional contexts
- The study emphasizes the complexity of technology adoption beyond simple supply-demand models
- Calls for understanding determinants to develop equitable health policy
Guideline-Based Recommendations
Diagnosis
- Utilize PET-CT for precise cancer diagnosis and treatment efficacy assessments
Management
- Address regional disparities in access to PET-CT technology
Monitoring & Follow-up
- Monitor the diffusion and utilization of PET-CT technology across regions
Risks
- Consider the implications of uneven access on health equity and socioeconomic health gaps
Patient & Prescribing Data
Cancer patients requiring advanced imaging techniques
PET-CT is recognized for its cost-effectiveness and efficacy in cancer treatment
Clinical Best Practices
- Incorporate multi-level contextual factors in the implementation of PET-CT technology
- Engage stakeholders in discussions to address barriers to technology adoption
- Promote standardization while recognizing local variations in practice
Related Resources & Content